Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mattsson

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Vox Sanguinis|May 4, 2017
Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantationJ Nilsson, I Granrot, J Mattsson, et al.
Bone Marrow Transplantation|September 3, 2008
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donorO Ringdén, M Okas, M Uhlin, et al.
Bone Marrow Transplantation|November 13, 2007
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survivalA-C Norlin, D Sairafi, J Mattsson, et al.
Thrombosis Research|September 27, 2005
Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosisJan-Arne E Björkman, Tommy I Abrahamsson, Viveca K Nerme, et al.
Planta|January 1, 1996
Studies on the role of the Arabidopsis gene MONOPTEROS in vascular development and plant cell axializationG K Przemeck, J Mattsson, C S Hardtke, et al.
Current Genetics|June 17, 1999
An exceptional group-I intron-like insertion in the SSU rDNA of lichen mycobiontsM Grube, B Gutmann, U Arup, et al.
Leukemia|February 16, 2000
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host diseaseJ Mattsson, M Uzunel, M Remberger, et al.
Clinical Transplantation|May 12, 1998
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontaminationS Carlens, O Ringdén, J Aschan, et al.
Bone Marrow Transplantation|May 9, 2000
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantationO Ringdén, M Remberger, S Lehmann, et al.
Transplantation Proceedings|November 20, 1997
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemiaS Carlens, O Ringdén, M Remberger, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Vox Sanguinis|May 4, 2017
Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantationJ Nilsson, I Granrot, J Mattsson, et al.
Bone Marrow Transplantation|September 3, 2008
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donorO Ringdén, M Okas, M Uhlin, et al.
Bone Marrow Transplantation|November 13, 2007
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survivalA-C Norlin, D Sairafi, J Mattsson, et al.
Thrombosis Research|September 27, 2005
Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosisJan-Arne E Björkman, Tommy I Abrahamsson, Viveca K Nerme, et al.
Planta|January 1, 1996
Studies on the role of the Arabidopsis gene MONOPTEROS in vascular development and plant cell axializationG K Przemeck, J Mattsson, C S Hardtke, et al.
Current Genetics|June 17, 1999
An exceptional group-I intron-like insertion in the SSU rDNA of lichen mycobiontsM Grube, B Gutmann, U Arup, et al.
Leukemia|February 16, 2000
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host diseaseJ Mattsson, M Uzunel, M Remberger, et al.
Clinical Transplantation|May 12, 1998
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontaminationS Carlens, O Ringdén, J Aschan, et al.
Bone Marrow Transplantation|May 9, 2000
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantationO Ringdén, M Remberger, S Lehmann, et al.
Transplantation Proceedings|November 20, 1997
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemiaS Carlens, O Ringdén, M Remberger, et al.
Pageof 15